Case Study UK’s Vaccine Taskforce
Assessment Case Study Overview United Kingdom’s Vaccine Taskforce and Covid-19 Vaccine Roll-out
Assignment Objectives (Your Task) – YOU MUST COMPLETE ALL SECTIONS:
• Critically examine the significance of culture in projects and how culture, using Hofstede’s Cultural dimensions framework, can be applied to facilitate the successful rollout of the Covid-19 Vaccine meeting the project’s aim. Justify your answer supported by evidence from the literature and linking to the case study (LO1).
• Critically examine project management leadership literature covering definitions of leadership using 2 project management leadership theories covered on the module and recommend a leadership style appropriate for rolling out the Covid-19 Vaccine (LO2). Please ensure you relate theory to the case study.
• Critically review and evaluate 2 managing change models (Kotter or Kübler-Ross or Lewin’s model) covered on the module and recommend one model that could be could be used or adapted as a suitable framework for rolling out the Covid-19 Vaccine thus improving people’s awareness and perception of the Covid-19 Vaccine and take-up. Justify your answer supported by the literature and link this to the case study (LO3).Assignment Objectives (Your Task) – YOU MUST COMPLETE ALL SECTIONS:
Whilst the UK Covid-19 Vaccine Roll-out encountered many well documented problems you are asked as a consultant to critically analyse lessons learned and the risks associated with the Covid-19 vaccine roll-out to develop a risk register in preparation for future vaccine rollouts. To meet this requirement, you will need to:
(i) Identify 10 risks
Review all the possible sources of risks related to the Covid-19 Vaccine roll-out. Making use of the vaccine roll-out objectives identify 10 risks, construct a risk register (with headings in the risk register as covered on the module workshop) making use of the risk meta language to describe the risks;
(ii) Analyse 10 risks
Qualitatively analyse the 10 risks in the risk register making use of the Probability*Impact scoring and show risks on a Probability*Impact Matrix
(iii) Respond to 10 risks For the 10 risks develop risk mitigating strategies (threats and opportunities) for each of the risks and include whether approach a Threat or Opportunity and then a single sentence mitigation strategy alongside the risk contained within the register .
(IV) Summarised commentary – most significant risks
Provide a summarised commentary of around 400 words of the most significant risks on the project (LO4).Useful Reports/Click Links Below
Rachael Pells (2021) ‘The Great Vaccine Roll-Out’, APM PROJECT SPRING 2021. IOG (2022) Caronavirus vaccine rollout, Institute for Government
https://www.instituteforgovernment.org.uk/explainers/coronavirus-vaccine-rollout
GOV (2021) VTF Objectives and Members of the Steering Group
https://www.gov.uk/government/publications/the-vaccine-taskforce-objectives-and- membership-of-steering-group/vtf-objectives-and-membership-of-the-steering-group
NAO (2022) ‘The rollout of the COVID-19 vaccination programme in England’, Session 2021-22, 25 February 2022, HC 1106.
https://www.nao.org.uk/reports/the-roll-out-of-the-covid-19-vaccine-in-england/
NHS Portsmouth (2022) Covid-10 Vaccination Centres launch across Hampshire and Isle of Wight
https://www.portsmouthccg.nhs.uk/covid-19-vaccination-centres-launch-across- hampshire-and-isle-of-wight/
Useful Reports/Click Links Below
Pfizer (2022) Manufacturing and Distributing the COVID-19 Vaccine
https://www.pfizer.com/science/coronavirus/vaccine/manufacturing-and-distribution
Alam S et al (2021) Challenges to COVID-19 vaccine supply chain: Implications for sustainable development goals, International Journal of Production Economics, Volume 239.
Mills C and Salisbury D (2021) The challenges of distributing COVID-19 vaccinations, Volume 31, EclinicalMedicine.
https://www.thelancet.com/pdfs/journals/eclinm/PIIS2589- 5370%2820%2930418-1.pdf
Or
https://www.thelancet.com/journals/eclinm/article/PIIS2589- 5370(20)30418-1/fulltext
Agile resilience in the UK: Lessons from COVID-19 for the ‘next normal’
https://www.mckinsey.com/capabilities/people-and-organizational-performance/our-insights/agile-resilience-in-the-uk-lessons-from-covid-19-for-the-next-normal
The post Case Study UK’s Vaccine Taskforce appeared first on Course Researchers.
